And they don't really have the inside view of what's happening at the FDA.” Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, ...
And they don't really have the inside view of what's happening at the FDA.” Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, ...
Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, and those can be pretty expensive. But the FTC hasn’t announced if ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given ...
The Federal Trade Commission (FTC) recently challenged over 100 drug patent listings and sent warning letters to 10 drug manufacturers of products ranging from inhalers to EpiPens. Putting drugmakers ...
But now, the FTC says drugmakers are gaming the system by filing what it described as “junk patents”. Those are patents that don’t really protect intellectual property or the innovation in h ...
Related: FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers The committee already has passed several bipartisan bills targeting "pay-for-delay" agreements ...
PETALING JAYA: Food ingredient supplier Agricore CS Holdings Bhd plans to raise RM25.9mil from its listing on the ACE Market of Bursa Malaysia. It plans to use RM18.9mil (74%) of the funds to ...
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to ...